医薬品用膜ろ過の世界市場予測(~2029):製品別、技術別、用途​​別、種類別、運営規模別

■ 英語タイトル:Pharmaceutical Membrane Filtration Market by Product (Filters (PES, PVDF, Nylon), Systems (Single use)), Technique (Microfiltration, Ultrafiltration), Application (API, Vaccines), Type (Sterile, Non Sterile), Scale of Operation - Global Forecast to 2029

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:BT2255-24)■ 発行会社/調査会社:MarketsandMarkets
■ 商品コード:BT2255-24
■ 発行日:2024年3月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:477
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[医薬品用膜ろ過の世界市場予測(~2029):製品別、技術別、用途​​別、種類別、運営規模別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

“医薬品用膜ろ過の世界市場は、2024年の106億米ドルから2029年には196億米ドルに達し、2024年から2029年の予測期間中の年平均成長率は13.1%と予測”この市場の成長は、最終用途産業における純度要求の高まりに起因しています。ライフサイエンス産業では、超純水はゲノミクス、プロテオミクス、免疫学、薬理学、細胞・組織培養、創薬に不可欠です。ライフサイエンス研究におけるタイプI、超純水、または研究グレードの水に対する需要の増加により、純粋な実験室用水の供給は、実験室産業において最も重要で急成長している市場の1つとなっています。この傾向は、今後数年間、医薬品用膜ろ過市場の成長を促進すると予想されます。

“2023年、無菌ろ過セグメントがタイプ別最大シェアを占める見込み”
2023年、世界の医薬品用膜ろ過市場において、無菌ろ過セグメントがタイプ別で最大のシェアを占めました。無菌ろ過は微生物除去のプロセスであり、最終製品の無菌性を保証する上で重要な役割を果たします。無菌フィルターは、液体医薬品の中間および最終ろ過に広く使用されています。規制当局によると、医薬品の最終製品加工には無菌グレードのフィルターが必要であり、最終製品加工において最も重要です。さらに、無菌フィルターには非無菌フィルターに比べて様々な利点があるため、製薬・バイオ医薬品産業の上流・下流工程で好んで使用されています。

“2024-2029年の予測期間中、米国が医薬品用膜ろ過市場を支配し続けると予測”
2023年の北米の医薬品用膜ろ過市場は米国が支配。米国は世界最大のバイオ医薬品市場であり、バイオ医薬品研究/投資のリーダーです。また、米国にはハーバード大学、スタンフォード大学、マサチューセッツ工科大学(MIT)など、世界有数の学術研究機関があります。これらの研究所では、創薬、ゲノム、バイオテクノロジーなどのライフサイエンス分野で最先端の研究が行われており、膜ろ過製品の使用が必要とされています。ろ過膜の技術的進歩や特許数の増加も、製薬・バイオテクノロジー産業におけるろ過の採用を後押ししています。

本レポートのために実施した一次インタビューは以下のように分類されます:
- 回答者別 供給側70%、需要側30%
- 役職別 管理職:45%、CXOおよび取締役:30%、経営幹部:25%
- 地域別 北米40%、欧州25%、アジア太平洋地域20%、中南米10%、中東・アフリカ5%

レポート掲載企業一覧
 Thermo Fisher Scientific Inc. (US)
 Merck KGaA (Germany)
 Danaher Corporation (US)
 Sartorius AG (Germany)
 Thermo Fisher Scientific, Inc. (US)
 3M Company (US)
 Parker Hannifin Corporation (US)
 Repligen Corporation (US)
 旭化成株式会社(日本)
 Eaton Corporation plc (Ireland)
 GEA Group (Germany)
 Corning Incorporated (US)
 Alfa Laval Corporate AB (Sweden)
 Donaldson Company, Inc. (US)
 Saint-Gobain (France)
 MANN+HUMMEL International GmbH & Co. KG (Germany)
 Meissner Filtration Products, Inc. (US)
 Cole-Parmer Instrument Company, LLC (US)
 Applexion (France)
 Cantel Medical Corp. (US)
 W. L. Gore & Associates Inc. (US)
 Membrane Solutions (US)
 Amazon Filters Ltd. (UK)
 東洋濾紙株式会社(日本)
 Porvair plc (UK)
 Sterlitech Corporation (US)
 Synder Filtration, Inc. (US)
 Graver Technologies, LLC (US)
 Koch Membrane Systems, Inc. (US)
 Nupore Filtration Systems (India)
 Cobetter Filtration Equipment Co., Ltd. (China)

調査範囲
本調査レポートは、医薬品用膜ろ過市場を製品別(メンブレンフィルター、システム、その他製品)、技術別(精密ろ過、限外ろ過、ナノろ過、その他技術)、用途別(最終製品加工、原料ろ過、細胞分離、浄水、空気浄化)、タイプ別(無菌ろ過、非無菌ろ過)、運用規模別(製造規模運用、パイロット規模運用、研究開発規模運用)、地域別(北米、欧州、アジア太平洋、中南米、中東、アフリカ)に分類しています。医薬品用膜ろ過市場の成長に影響を与える促進要因、阻害要因、課題、機会などの主要要因に関する詳細情報を網羅しています。主要な産業プレイヤーを詳細に分析し、事業概要、製品、ソリューション、主要戦略、提携、パートナーシップ、契約に関する洞察を提供します。医薬品用膜ろ過市場に関連する新発売、提携、買収、最近の動向。

レポート購入の主な利点
本レポートは、医薬品用膜ろ過市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダーや新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します:
- 市場の成長に影響を与える主要な促進要因(シングルユース技術の採用の増加、厳しい規制要件、製薬・バイオテクノロジー産業における研究開発費の増加、最終用途産業における純度要件の増加)、阻害要因(膜のファウリング問題、中小企業の参入を制限する高い設備投資要件)、機会(新興国における機会の増加、ナノろ過技術の進歩)、課題(コストの増加、フィルターの速度と収率の低下)の分析。
- 製品開発/イノベーション: 医薬品用膜ろ過市場の新発売製品に関する詳細な洞察
- 市場開発: 有利な市場に関する包括的な情報 - 本レポートでは様々な地域の市場を分析しています。
- 市場の多様化: 医薬品用膜ろ過市場における新製品、未開拓地域、最近の開発、投資に関する詳細情報
- 競合他社の評価:Merck KGaA(ドイツ)、Danaher Corporation(米国)、Sartorius AG(ドイツ)、Thermo Fisher Scientific, Inc.(米国)、3M Company(米国)、Parker Hannifin Corporation(米国)、Repligen Corporation(米国)、旭化成株式会社(日本)、Eaton Corporation plc(アイルランド)、GEA Group(ドイツ)、Corning Incorporated(米国)、Alfa Laval Corporate AB(スウェーデン)、Donaldson Company, Inc. (米国)など。

1 はじめに
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 医薬品用膜ろ過市場:製品別
7 医薬品用膜ろ過市場:技術別
8 医薬品用膜ろ過市場:用途別
9 医薬品用膜ろ過市場:種類別
10 医薬品用膜ろ過市場:運営規模別
11 医薬品用膜ろ過市場:地域別
12 競争状況
13 企業プロファイル
14 付録

*** レポート目次(コンテンツ)***

1 INTRODUCTION 68
1.1 STUDY OBJECTIVES 68
1.2 MARKET DEFINITION 68
1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY 69
1.3 STUDY SCOPE 70
1.3.1 MARKET SEGMENTATION 70
1.3.2 REGIONS COVERED 71
1.4 YEARS CONSIDERED 71
1.5 CURRENCY 72
1.6 STAKEHOLDERS 72
1.7 LIMITATIONS 72
1.8 SUMMARY OF CHANGES 73
1.9 RECESSION IMPACT 74
2 RESEARCH METHODOLOGY 75
2.1 RESEARCH DATA 75
FIGURE 1 RESEARCH DESIGN 75
2.1.1 SECONDARY DATA 76
2.1.2 PRIMARY DATA 77
FIGURE 2 BREAKDOWN OF PRIMARIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET 77
2.2 MARKET ESTIMATION METHODOLOGY 78
FIGURE 3 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 78
2.2.1 BOTTOM-UP APPROACH 78
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 79
FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SARTORIUS AG (2023) 79
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 81
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 81
2.2.3 TOP-DOWN APPROACH 81
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 81
2.3 GROWTH FORECAST 82
FIGURE 8 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: CAGR PROJECTIONS 83
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 84
FIGURE 9 DATA TRIANGULATION METHODOLOGY 84
2.5 RESEARCH ASSUMPTIONS 85
2.6 MARKET FORECAST 85
TABLE 1 FACTOR ANALYSIS 85
2.7 RISK ANALYSIS 86
2.8 RECESSION IMPACT ANALYSIS 86
3 EXECUTIVE SUMMARY 88
FIGURE 10 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 88
FIGURE 11 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION) 89
FIGURE 12 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 90
FIGURE 13 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 91
FIGURE 14 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2024 VS. 2029 (USD MILLION) 91
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL MEMBRANE FILTRATION MARKET 92
4 PREMIUM INSIGHTS 94
4.1 PHARMACEUTICAL MEMBRANE FILTRATION MARKET OVERVIEW 94
FIGURE 16 RISING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH 94
4.2 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT AND COUNTRY (2023) 95
FIGURE 17 MEMBRANE FILTERS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL MEMBRANE FILTRATION MARKET IN 2023 95
4.3 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE, BY APPLICATION, 2024 VS. 2029 95
FIGURE 18 FINAL PRODUCT PROCESSING SEGMENT TO DOMINATE MARKET IN 2029 95
4.4 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE, BY TECHNIQUE, 2023 96
FIGURE 19 MICROFILTRATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 96
4.5 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 97
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029 97
5 MARKET OVERVIEW 98
5.1 INTRODUCTION 98
5.2 MARKET DYNAMICS 98
FIGURE 21 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 98
TABLE 2 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: IMPACT ANALYSIS 99
5.2.1 DRIVERS 99
5.2.1.1 Increasing adoption of single-use technologies 99
5.2.1.2 Stringent regulatory requirements 100
5.2.1.3 Rising R&D spending in pharmaceutical and biotechnology industries 100
FIGURE 22 PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION) 101
5.2.1.4 Increasing purity requirements in end-use industries 101
5.2.2 RESTRAINTS 102
5.2.2.1 Membrane fouling issues 102
5.2.2.2 High capital investment requirements to limit entry of smaller players 102
5.2.3 OPPORTUNITIES 103
5.2.3.1 Growth opportunities in emerging economies 103
5.2.3.2 Advances in nanofiltration technology 103
5.2.4 CHALLENGES 104
5.2.4.1 Increased cost and reduced speed & yield of filters 104
5.3 TECHNOLOGY ANALYSIS 104
TABLE 3 TECHNOLOGY ANALYSIS 104
5.4 SUPPLY CHAIN ANALYSIS 105
FIGURE 23 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: SUPPLY CHAIN ANALYSIS 105
5.5 VALUE CHAIN ANALYSIS 106
FIGURE 24 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: VALUE CHAIN ANALYSIS 107
5.6 ECOSYSTEM ANALYSIS 108
FIGURE 25 PHARMACEUTICAL MEMBRANE FILTRATION MARKET ECOSYSTEM 108
5.6.1 PHARMACEUTICAL MEMBRANE FILTRATION RAW MATERIAL SUPPLIERS 109
TABLE 4 PHARMACEUTICAL MEMBRANE FILTRATION RAW MATERIAL SUPPLIERS 109
5.6.2 PHARMACEUTICAL MEMBRANE FILTRATION VENDORS 109
TABLE 5 PHARMACEUTICAL MEMBRANE FILTRATION VENDORS 109
5.6.3 PHARMACEUTICAL MEMBRANE FILTRATION END USERS 110
TABLE 6 PHARMACEUTICAL MEMBRANE FILTRATION END USERS 110
5.6.4 PHARMACEUTICAL MEMBRANE FILTRATION REGULATORY BODIES 111
TABLE 7 PHARMACEUTICAL MEMBRANE FILTRATION REGULATORY BODIES 111
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 111
FIGURE 26 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: TRENDS/DISRUPTIONS IMPACTING CLIENT’S BUSINESS 111
5.8 PRICING ANALYSIS 113
TABLE 8 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 113
5.8.1 AVERAGE SELLING PRICE RANGE, BY REGION, 2023 113
TABLE 9 AVERAGE SELLING PRICE, BY REGION, 2023 113
5.9 REGULATORY LANDSCAPE 114
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 115
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 115
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
5.9.2 REGULATORY SCENARIO IN DIFFERENT COUNTRIES 117
5.10 PATENT ANALYSIS 118
5.10.1 METHODOLOGY 118
5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2013–2023 118
TABLE 15 PATENTS FILED, 2013–2023 118
5.10.3 INNOVATION AND PATENT APPLICATIONS 118
FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014–2023 118
5.10.4 TOP APPLICANTS 119
FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2023 119
TABLE 16 TOP 20 PATENT OWNERS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2014–2023 119
TABLE 17 PATENTS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2023 120
5.11 INVESTMENT/FUNDING ACTIVITIES 121
5.12 KEY CONFERENCES AND EVENTS, 2024 122
TABLE 18 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024 122
5.13 PORTER’S FIVE FORCES ANALYSIS 123
TABLE 19 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 123
5.13.1 THREAT OF NEW ENTRANTS 123
5.13.2 THREAT OF SUBSTITUTES 123
5.13.3 BARGAINING POWER OF BUYERS 124
5.13.4 BARGAINING POWER OF SUPPLIERS 124
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 124
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 125
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 125
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PHARMACEUTICAL MEMBRANE FILTRATION PRODUCTS 125
5.14.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL MEMBRANE FILTRATION PRODUCTS AMONG END USERS 125
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 125
TABLE 20 BUYING CRITERIA FOR PHARMACEUTICAL MEMBRANE FILTRATION, BY END USER 126
5.15 CASE STUDY ANALYSIS 127
5.15.1 CASE STUDY 1: PELLICON 2 CASSETTE PROCESSING OF THERAPEUTIC PROTEINS 127
5.15.2 CASE STUDY 2: FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID 127
5.15.3 CASE STUDY 3: 3M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS 127
5.15.4 CASE STUDY 4: DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS 128
5.15.5 CASE STUDY 5: USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS 128
6 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT 129
6.1 INTRODUCTION 130
TABLE 21 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 130
6.2 MEMBRANE FILTERS 130
TABLE 22 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 131
TABLE 23 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 132
TABLE 24 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 25 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 26 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 27 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 28 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 134
TABLE 29 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
6.2.1 POLYETHERSULFONE MEMBRANE FILTERS 135
6.2.1.1 Wide use of hydrophilic PES membranes in sterilizing applications to drive growth 135
TABLE 30 POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 31 NORTH AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 32 EUROPE: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 33 ASIA PACIFIC: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 34 LATIN AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 35 MIDDLE EAST: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 138
TABLE 36 GCC COUNTRIES: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
6.2.2 POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS 138
6.2.2.1 Non-toxic, highly pure, and biologically safe—advantages supporting market growth 138
TABLE 37 POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 139
TABLE 38 NORTH AMERICA: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 39 EUROPE: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 40 ASIA PACIFIC: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 41 LATIN AMERICA: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 42 MIDDLE EAST: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 141
TABLE 43 GCC COUNTRIES: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.2.3 NYLON MEMBRANE FILTERS 142
6.2.3.1 Increased endotoxin adsorption capacity to drive growth 142
TABLE 44 NYLON MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 45 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 46 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 47 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 48 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 49 MIDDLE EAST: NYLON MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 50 GCC COUNTRIES: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
6.2.4 POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS 145
6.2.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ 145
TABLE 51 POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 145
TABLE 52 NORTH AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 53 EUROPE: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 54 ASIA PACIFIC: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 55 LATIN AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 56 MIDDLE EAST: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 147
TABLE 57 GCC COUNTRIES: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147
6.2.5 MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS 148
6.2.5.1 Provide optically compatible surface for greater adsorption of products 148
TABLE 58 MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 148
TABLE 59 NORTH AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 60 EUROPE: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 61 ASIA PACIFIC: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 62 LATIN AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 63 MIDDLE EAST: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 151
TABLE 64 GCC COUNTRIES: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
6.2.6 POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS 151
6.2.6.1 Widely used in cell biology and analytical testing applications 151
TABLE 65 POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 152
TABLE 66 NORTH AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 67 EUROPE: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 68 ASIA PACIFIC: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 69 LATIN AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 70 MIDDLE EAST: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 154
TABLE 71 GCC COUNTRIES: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
6.2.7 OTHER MEMBRANE FILTERS 155
TABLE 72 OTHER MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 156
TABLE 73 NORTH AMERICA: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 74 EUROPE: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 75 ASIA PACIFIC: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 76 LATIN AMERICA: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 77 MIDDLE EAST: OTHER MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 78 GCC COUNTRIES: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
6.3 SYSTEMS 159
TABLE 79 PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 159
TABLE 80 PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 160
TABLE 81 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 82 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 83 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 84 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 85 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 86 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
6.3.1 SINGLE-USE SYSTEMS 163
6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 163
TABLE 87 SINGLE-USE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 163
TABLE 88 NORTH AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 89 EUROPE: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 90 ASIA PACIFIC: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 91 LATIN AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 92 MIDDLE EAST: SINGLE-USE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 165
TABLE 93 GCC COUNTRIES: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 166
6.3.2 REUSABLE SYSTEMS 166
6.3.2.1 Widely used for large-scale manufacturing 166
TABLE 94 REUSABLE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 95 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 96 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 97 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 98 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 99 MIDDLE EAST: REUSABLE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 168
TABLE 100 GCC COUNTRIES: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169
6.4 OTHER PRODUCTS 169
TABLE 101 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 102 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 170
TABLE 103 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 104 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 105 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 106 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 107 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 172
TABLE 108 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 172
6.4.1 MEMBRANE FILTRATION ASSEMBLIES 173
6.4.1.1 Leading players provide pre-assembled filtration assemblies 173
TABLE 109 MEMBRANE FILTRATION ASSEMBLIES MARKET, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 110 NORTH AMERICA: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 111 EUROPE: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 112 ASIA PACIFIC: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 113 LATIN AMERICA: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175
TABLE 114 MIDDLE EAST: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY REGION, 2022–2029 (USD MILLION) 175
TABLE 115 GCC COUNTRIES: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175
6.4.2 ACCESSORIES 176
6.4.2.1 Increasing adoption of pharmaceutical membrane filtration products to support growth 176
TABLE 116 PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 176
TABLE 117 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 118 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 119 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 120 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 121 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 178
TABLE 122 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178
7 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE 179
7.1 INTRODUCTION 180
TABLE 123 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 180
7.2 MICROFILTRATION 180
7.2.1 AVAILABILITY OF INNOVATIVE AND COST-EFFECTIVE MICROFILTRATION MEMBRANES TO SUPPORT MARKET GROWTH 180
TABLE 124 PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 181
TABLE 125 NORTH AMERICA: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 126 EUROPE: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 127 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 128 LATIN AMERICA: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 129 MIDDLE EAST: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 183
TABLE 130 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
7.3 ULTRAFILTRATION 184
7.3.1 LEAST COSTLY TECHNIQUE TO OPERATE 184
TABLE 131 PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 184
TABLE 132 NORTH AMERICA: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 133 EUROPE: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 134 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 135 LATIN AMERICA: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 136 MIDDLE EAST: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 187
TABLE 137 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187
7.4 NANOFILTRATION 187
7.4.1 HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH 187
TABLE 138 PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 188
TABLE 139 NORTH AMERICA: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 140 EUROPE: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 141 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 142 LATIN AMERICA: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 143 MIDDLE EAST: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 190
TABLE 144 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190
7.5 OTHER TECHNIQUES 191
TABLE 145 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION) 191
TABLE 146 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 147 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 148 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 149 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 150 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION) 193
TABLE 151 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 193
8 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION 194
8.1 INTRODUCTION 195
TABLE 152 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 195
8.2 FINAL PRODUCT PROCESSING 195
TABLE 153 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 154 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2022–2029 (USD MILLION) 196
TABLE 155 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 156 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 157 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 158 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 159 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2022–2029 (USD MILLION) 199
TABLE 160 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 199
8.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION 199
8.2.1.1 Continuous requirement for API filtration to drive market 199
TABLE 161 ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 200
TABLE 162 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 163 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 164 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 165 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 166 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 202
TABLE 167 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
8.2.2 PROTEIN PURIFICATION 203
8.2.2.1 Advancements in protein therapeutic drugs to propel growth 203
TABLE 168 PROTEIN PURIFICATION MARKET, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 169 NORTH AMERICA: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 170 EUROPE: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 171 ASIA PACIFIC: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 172 LATIN AMERICA: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 173 MIDDLE EAST: PROTEIN PURIFICATION MARKET, BY REGION, 2022–2029 (USD MILLION) 205
TABLE 174 GCC COUNTRIES: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206
8.2.3 VACCINE AND ANTIBODY PROCESSING 206
8.2.3.1 Rising investments in life science R&D to drive growth 206
TABLE 175 VACCINE AND ANTIBODY PROCESSING MARKET, BY REGION, 2022–2029 (USD MILLION) 206
TABLE 176 NORTH AMERICA: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 177 EUROPE: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 178 ASIA PACIFIC: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 179 LATIN AMERICA: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 180 MIDDLE EAST: VACCINE AND ANTIBODY PROCESSING MARKET, BY REGION, 2022–2029 (USD MILLION) 209
TABLE 181 GCC COUNTRIES: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209
8.2.4 FORMULATION AND FILLING SOLUTIONS 209
8.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth 209
TABLE 182 FORMULATION AND FILLING SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 210
TABLE 183 NORTH AMERICA: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 184 EUROPE: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 185 ASIA PACIFIC: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 186 LATIN AMERICA: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 187 MIDDLE EAST: FORMULATION AND FILLING SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 212
TABLE 188 GCC COUNTRIES: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212
8.2.5 VIRAL CLEARANCE 213
8.2.5.1 Development of therapeutic monoclonal antibodies to drive market 213
TABLE 189 VIRAL CLEARANCE MARKET, BY REGION, 2022–2029 (USD MILLION) 213
TABLE 190 NORTH AMERICA: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 191 EUROPE: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 192 ASIA PACIFIC: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 193 LATIN AMERICA: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 194 MIDDLE EAST: VIRAL CLEARANCE MARKET, BY REGION, 2022–2029 (USD MILLION) 215
TABLE 195 GCC COUNTRIES: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216

8.3 RAW MATERIAL FILTRATION 216
TABLE 196 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 197 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2022–2029 (USD MILLION) 217
TABLE 198 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 217
TABLE 199 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 200 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 201 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 202 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2022–2029 (USD MILLION) 219
TABLE 203 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION) 219
8.3.1 MEDIA AND BUFFER FILTRATION 220
8.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market 220
TABLE 204 MEDIA AND BUFFER FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 220
TABLE 205 NORTH AMERICA: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 221
TABLE 206 EUROPE: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 221
TABLE 207 ASIA PACIFIC: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 222
TABLE 208 LATIN AMERICA: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 222
TABLE 209 MIDDLE EAST: MEDIA AND BUFFER FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 223
TABLE 210 GCC COUNTRIES: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 223
8.3.2 PREFILTRATION 223
8.3.2.1 Membrane fouling issues to support market growth 223
TABLE 211 PREFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 224
TABLE 212 NORTH AMERICA: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 224
TABLE 213 EUROPE: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 214 ASIA PACIFIC: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 215 LATIN AMERICA: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 226
TABLE 216 MIDDLE EAST: PREFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 226
TABLE 217 GCC COUNTRIES: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 226
8.3.3 BIOBURDEN TESTING 227
8.3.3.1 Strict quality control of biopharmaceuticals to propel growth 227
TABLE 218 BIOBURDEN TESTING MARKET, BY REGION, 2022–2029 (USD MILLION) 227
TABLE 219 NORTH AMERICA: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 227
TABLE 220 EUROPE: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 228
TABLE 221 ASIA PACIFIC: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 228
TABLE 222 LATIN AMERICA: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 229
TABLE 223 MIDDLE EAST: BIOBURDEN TESTING MARKET, BY REGION, 2022–2029 (USD MILLION) 229
TABLE 224 GCC COUNTRIES: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 229
8.4 CELL SEPARATION 230
8.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET 230
TABLE 225 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2022–2029 (USD MILLION) 230
TABLE 226 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 227 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION) 231
TABLE 228 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION) 231
TABLE 229 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION) 232
TABLE 230 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2022–2029 (USD MILLION) 232
TABLE 231 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION) 232
8.5 WATER PURIFICATION 233
8.5.1 INCREASING DEMAND FOR PURIFIED WATER FROM HOSPITALS TO DRIVE MARKET 233
TABLE 232 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2022–2029 (USD MILLION) 233
TABLE 233 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 234 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 234
TABLE 235 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 234
TABLE 236 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 235
TABLE 237 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2022–2029 (USD MILLION) 235
TABLE 238 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 235
8.6 AIR PURIFICATION 236
8.6.1 INCREASING ADOPTION OF GMP PRACTICES TO SUPPORT MARKET GROWTH 236
TABLE 239 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2022–2029 (USD MILLION) 236
TABLE 240 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 237
TABLE 241 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 237
TABLE 242 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 238
TABLE 243 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 238
TABLE 244 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2022–2029 (USD MILLION) 238
TABLE 245 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 239
9 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE 240
9.1 INTRODUCTION 241
TABLE 246 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
9.2 STERILE FILTRATION 241
9.2.1 GROWING DEMAND FOR BIOLOGICS DRUGS TO DRIVE DEMAND 241
TABLE 247 PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 242
TABLE 248 NORTH AMERICA: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 242
TABLE 249 EUROPE: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 243
TABLE 250 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 243
TABLE 251 LATIN AMERICA: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 244
TABLE 252 MIDDLE EAST: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 244
TABLE 253 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 244
9.3 NON-STERILE FILTRATION 245
9.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROPEL MARKET 245
TABLE 254 PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 245
TABLE 255 NORTH AMERICA: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 245
TABLE 256 EUROPE: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 246
TABLE 257 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 246
TABLE 258 LATIN AMERICA: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 247
TABLE 259 MIDDLE EAST: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 247
TABLE 260 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 247
10 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION 248
10.1 INTRODUCTION 249
TABLE 261 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 249
10.2 MANUFACTURING SCALE 249
10.2.1 GROWTH IN MANUFACTURING OF BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET 249
TABLE 262 MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 250
TABLE 263 NORTH AMERICA: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 251
TABLE 264 EUROPE: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 251
TABLE 265 ASIA PACIFIC: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 252
TABLE 266 LATIN AMERICA: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 252
TABLE 267 MIDDLE EAST: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 253
TABLE 268 GCC COUNTRIES: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 253
10.3 PILOT SCALE 253
10.3.1 INCREASED OUTSOURCING TO DRIVE MARKET GROWTH 253
TABLE 269 PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 254
TABLE 270 NORTH AMERICA: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 254
TABLE 271 EUROPE: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 255
TABLE 272 ASIA PACIFIC: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 255
TABLE 273 LATIN AMERICA: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 256
TABLE 274 MIDDLE EAST: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 256
TABLE 275 GCC COUNTRIES: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 256
10.4 R&D SCALE 257
10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH 257
TABLE 276 R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 257
TABLE 277 NORTH AMERICA: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 258
TABLE 278 EUROPE: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 258
TABLE 279 ASIA PACIFIC: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 259
TABLE 280 LATIN AMERICA: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 259
TABLE 281 MIDDLE EAST: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 260
TABLE 282 GCC COUNTRIES: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 260
11 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION 261
11.1 INTRODUCTION 262
TABLE 283 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 262
11.2 NORTH AMERICA 262
FIGURE 31 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SNAPSHOT 263
TABLE 284 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 264
TABLE 285 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 264
TABLE 286 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 265
TABLE 287 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 265
TABLE 288 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 266
TABLE 289 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 266
TABLE 290 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 267
TABLE 291 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 267
TABLE 292 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 268
TABLE 293 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 268
TABLE 294 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 268
11.2.1 US 269
11.2.1.1 Technological advancements in filtration membranes to support market growth 269
TABLE 295 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 269
TABLE 296 US: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 270
TABLE 297 US: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 270
TABLE 298 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 271
TABLE 299 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 271
TABLE 300 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 272
TABLE 301 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 272
TABLE 302 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 273
TABLE 303 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 273
TABLE 304 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 273
11.2.2 CANADA 274
11.2.2.1 Growing government support for expanding manufacturing facilities to drive market 274
TABLE 305 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 274
TABLE 306 CANADA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 275
TABLE 307 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 275
TABLE 308 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 276
TABLE 309 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 276
TABLE 310 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 277
TABLE 311 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 312 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 278
TABLE 313 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 278
TABLE 314 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 278
11.2.3 NORTH AMERICA: RECESSION IMPACT 279
11.3 EUROPE 279
TABLE 315 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 280
TABLE 316 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 280
TABLE 317 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 318 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 319 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 282
TABLE 320 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 282
TABLE 321 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 283
TABLE 322 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 283
TABLE 323 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 284
TABLE 324 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 284
TABLE 325 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 284
11.3.1 GERMANY 285
11.3.1.1 Growing pharmaceutical R&D and manufacturing to drive market 285
TABLE 326 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 285
TABLE 327 GERMANY: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 328 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 329 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 287
TABLE 330 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 287
TABLE 331 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 288
TABLE 332 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 288
TABLE 333 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 289
TABLE 334 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 289
TABLE 335 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 289
11.3.2 UK 290
11.3.2.1 Increased R&D investments and government aid to boost market growth 290
TABLE 336 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 290
TABLE 337 UK: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 338 UK: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 339 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 292
TABLE 340 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 292
TABLE 341 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 293
TABLE 342 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 293
TABLE 343 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 344 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 345 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 294
11.3.3 FRANCE 295
11.3.3.1 Increasing government investments in pharmaceutical industry to drive growth 295
TABLE 346 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 295
TABLE 347 FRANCE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 296
TABLE 348 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 296
TABLE 349 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 297
TABLE 350 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 297
TABLE 351 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 298
TABLE 352 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 298
TABLE 353 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 299
TABLE 354 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 299
TABLE 355 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 299
11.3.4 ITALY 300
11.3.4.1 Rising research activities in pharma R&D to boost market growth 300
TABLE 356 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 300
TABLE 357 ITALY: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 301
TABLE 358 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 301
TABLE 359 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 302
TABLE 360 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 302
TABLE 361 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 303
TABLE 362 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 303
TABLE 363 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 304
TABLE 364 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 304
TABLE 365 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 304
11.3.5 SPAIN 305
11.3.5.1 Expansion of biomanufacturing facilities to support market growth 305
TABLE 366 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 305
TABLE 367 SPAIN: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 306
TABLE 368 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 306
TABLE 369 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 307
TABLE 370 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 307
TABLE 371 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 308
TABLE 372 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 308
TABLE 373 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 309
TABLE 374 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 309
TABLE 375 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 309
11.3.6 REST OF EUROPE 310
TABLE 376 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 310
TABLE 377 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 311
TABLE 378 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 311
TABLE 379 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 312
TABLE 380 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 312
TABLE 381 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 313
TABLE 382 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 313
TABLE 383 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 314
TABLE 384 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 314
TABLE 385 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 314
11.3.7 EUROPE: RECESSION IMPACT 315
11.4 ASIA PACIFIC 315
FIGURE 32 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SNAPSHOT 316
TABLE 386 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 317
TABLE 387 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 317
TABLE 388 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 318
TABLE 389 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 318
TABLE 390 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 319
TABLE 391 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 319
TABLE 392 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 320
TABLE 393 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 320
TABLE 394 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 321
TABLE 395 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 321
TABLE 396 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 321
11.4.1 CHINA 322
11.4.1.1 China to dominate Asia Pacific market during forecast period 322
TABLE 397 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 322
TABLE 398 CHINA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 323
TABLE 399 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 323
TABLE 400 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 324
TABLE 401 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 324
TABLE 402 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 325
TABLE 403 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 325
TABLE 404 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 326
TABLE 405 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 326
TABLE 406 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 326
11.4.2 JAPAN 327
11.4.2.1 Stringent regulatory guidelines to increase demand for advanced filtration products 327
TABLE 407 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 327
TABLE 408 JAPAN: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 328
TABLE 409 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 328
TABLE 410 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 329
TABLE 411 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 329
TABLE 412 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 330
TABLE 413 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 330
TABLE 414 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 331
TABLE 415 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 331
TABLE 416 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 331
11.4.3 INDIA 332
11.4.3.1 Government initiatives to favor market growth 332
TABLE 417 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 332
TABLE 418 INDIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 333
TABLE 419 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 333
TABLE 420 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 334
TABLE 421 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 334
TABLE 422 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 335
TABLE 423 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 335
TABLE 424 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 336
TABLE 425 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 336
TABLE 426 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 336
11.4.4 SOUTH KOREA 337
11.4.4.1 Increased export of drugs to support market growth 337
TABLE 427 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 337
TABLE 428 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 338
TABLE 429 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 338
TABLE 430 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 339
TABLE 431 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 339
TABLE 432 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 340
TABLE 433 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 340
TABLE 434 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 341
TABLE 435 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 341
TABLE 436 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 341
11.4.5 AUSTRALIA 342
11.4.5.1 Increasing demand for innovative filtration solutions to propel market 342
TABLE 437 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 342
TABLE 438 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 343
TABLE 439 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 343
TABLE 440 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 344
TABLE 441 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 344
TABLE 442 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 345
TABLE 443 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 345
TABLE 444 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 346
TABLE 445 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 346
TABLE 446 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 346
11.4.6 REST OF ASIA PACIFIC 347
TABLE 447 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 347
TABLE 448 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 348
TABLE 449 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 348
TABLE 450 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 349
TABLE 451 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 349
TABLE 452 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 350
TABLE 453 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 350
TABLE 454 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 351
TABLE 455 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 351
TABLE 456 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 351
11.4.7 ASIA PACIFIC: RECESSION IMPACT 352

11.5 LATIN AMERICA 353
TABLE 457 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 353
TABLE 458 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 353
TABLE 459 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 354
TABLE 460 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 354
TABLE 461 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 355
TABLE 462 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 355
TABLE 463 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 356
TABLE 464 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 356
TABLE 465 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 357
TABLE 466 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 357
TABLE 467 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 357
11.5.1 BRAZIL 358
11.5.1.1 Growth of vaccine manufacturing to drive market 358
TABLE 468 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 358
TABLE 469 BRAZIL: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 359
TABLE 470 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 359
TABLE 471 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 360
TABLE 472 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 360
TABLE 473 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 361
TABLE 474 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 361
TABLE 475 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 362
TABLE 476 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 362
TABLE 477 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 362
11.5.2 MEXICO 363
11.5.2.1 Rising demand for chronic disease treatment to support market growth 363
TABLE 478 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 363
TABLE 479 MEXICO: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 364
TABLE 480 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 364
TABLE 481 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 365
TABLE 482 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 365
TABLE 483 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 366
TABLE 484 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 366
TABLE 485 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 367
TABLE 486 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 367
TABLE 487 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 367
11.5.3 REST OF LATIN AMERICA 368
TABLE 488 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 368
TABLE 489 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 368
TABLE 490 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 369
TABLE 491 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 369
TABLE 492 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 369
TABLE 493 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 370
TABLE 494 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 370
TABLE 495 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 371
TABLE 496 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 371
TABLE 497 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 371
11.5.4 LATIN AMERICA: RECESSION IMPACT 372
11.6 MIDDLE EAST 372
TABLE 498 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 372
TABLE 499 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 373
TABLE 500 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 373
TABLE 501 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 374
TABLE 502 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 374
TABLE 503 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 374
TABLE 504 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 375
TABLE 505 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 375
TABLE 506 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 376
TABLE 507 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 376
TABLE 508 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 376
11.6.1 GCC COUNTRIES 377
TABLE 509 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 377
TABLE 510 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 377
TABLE 511 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 378
TABLE 512 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 378
TABLE 513 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 379
TABLE 514 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 379
TABLE 515 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 380
TABLE 516 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 380
TABLE 517 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 381
TABLE 518 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 381
TABLE 519 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 381
11.6.1.1 Saudi Arabia 382
11.6.1.1.1 Growing healthcare expenditure to boost market growth 382
TABLE 520 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 382
TABLE 521 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 383
TABLE 522 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 383
TABLE 523 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 384
TABLE 524 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 384
TABLE 525 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 385
TABLE 526 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 385
TABLE 527 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 386
TABLE 528 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 386
TABLE 529 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 386
11.6.1.2 UAE 387
11.6.1.2.1 Rapidly growing pharmaceutical industry to aid market growth 387
TABLE 530 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 387
TABLE 531 UAE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 388
TABLE 532 UAE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 388
TABLE 533 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 389
TABLE 534 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 389
TABLE 535 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 390
TABLE 536 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 390
TABLE 537 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 391
TABLE 538 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 391
TABLE 539 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 391
11.6.1.3 Rest of GCC countries 392
TABLE 540 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 392
TABLE 541 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 392
TABLE 542 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 393
TABLE 543 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 393
TABLE 544 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 393
TABLE 545 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 394
TABLE 546 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 394
TABLE 547 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 395
TABLE 548 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 395
TABLE 549 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 395
11.6.2 REST OF MIDDLE EAST 396
TABLE 550 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 396
TABLE 551 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 396
TABLE 552 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 397
TABLE 553 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 397
TABLE 554 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 397
TABLE 555 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 398
TABLE 556 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 398
TABLE 557 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 399
TABLE 558 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 399
TABLE 559 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 399
11.6.3 MIDDLE EAST: RECESSION IMPACT 400
11.7 AFRICA 400
11.7.1 GROWING MARKET FOR PHARMACEUTICALS AND INCREASING DEMAND FOR DRUGS TO PROPEL MARKET 400
TABLE 560 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 400
TABLE 561 AFRICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 401
TABLE 562 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 401
TABLE 563 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 402
TABLE 564 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 402
TABLE 565 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 403
TABLE 566 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 403
TABLE 567 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 404
TABLE 568 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 404
TABLE 569 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 404
11.7.2 AFRICA: RECESSION IMPACT 405
12 COMPETITIVE LANDSCAPE 406
12.1 INTRODUCTION 406
12.2 STRATEGIES ADOPTED BY KEY PLAYERS 406
TABLE 570 STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2022−2024 406
12.3 REVENUE SHARE ANALYSIS 407
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 (USD MILLION) 407
12.4 MARKET SHARE ANALYSIS 408
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 408
TABLE 571 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DEGREE OF COMPETITION 409
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 410
12.5.1 STARS 410
12.5.2 EMERGING LEADERS 410
12.5.3 PERVASIVE PLAYERS 410
12.5.4 PARTICIPANTS 411
FIGURE 35 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 411
12.6 COMPETITIVE BENCHMARKING OF KEY PLAYERS 412
12.6.1 COMPANY FOOTPRINT 412
FIGURE 36 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY FOOTPRINT 412
12.6.2 PRODUCT FOOTPRINT 413
TABLE 572 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PRODUCT FOOTPRINT 413
12.6.3 SCALE OF OPERATION FOOTPRINT 414
TABLE 573 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: SCALE OF OPERATION FOOTPRINT 414
12.6.4 REGIONAL FOOTPRINT 415
TABLE 574 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: REGIONAL FOOTPRINT 415
12.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES 416
12.7.1 PROGRESSIVE COMPANIES 416
12.7.2 STARTING BLOCKS 416
12.7.3 RESPONSIVE COMPANIES 416
12.7.4 DYNAMIC COMPANIES 416
FIGURE 37 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 417
12.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 418
TABLE 575 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 418
TABLE 576 PHARMACEUTICAL MEMBRANE FILTRATION: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 419
12.9 VALUATION AND FINANCIAL METRICS OF PHARMACEUTICAL MEMBRANE FILTRATION VENDORS 420
FIGURE 38 EV/EBITDA OF KEY VENDORS 420
FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 420
12.10 BRAND/PRODUCT COMPARATIVE ANALYSIS 421
12.10.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 421
FIGURE 40 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 421
12.11 COMPETITIVE SCENARIO 422
12.11.1 PRODUCT LAUNCHES 422
TABLE 577 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2024 422
12.11.2 DEALS 422
TABLE 578 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DEALS, JANUARY 2021–JANUARY 2024 422
12.11.3 EXPANSIONS 423
TABLE 579 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2024 423
13 COMPANY PROFILES 425
13.1 KEY PLAYERS 425
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 MERCK KGAA 425
TABLE 580 MERCK KGAA: BUSINESS OVERVIEW 425
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022) 426
TABLE 581 MERCK KGAA: PRODUCTS OFFERED 426
TABLE 582 MERCK KGAA: DEALS 427
TABLE 583 MERCK KGAA: OTHER DEVELOPMENTS 428
13.1.2 DANAHER CORPORATION 430
TABLE 584 DANAHER CORPORATION: BUSINESS OVERVIEW 430
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 431
TABLE 585 DANAHER CORPORATION: PRODUCTS OFFERED 431
TABLE 586 DANAHER CORPORATION: DEALS 433
TABLE 587 DANAHER CORPORATION: EXPANSIONS 434
13.1.3 SARTORIUS AG 436
TABLE 588 SARTORIUS AG: BUSINESS OVERVIEW 436
FIGURE 43 SARTORIUS AG: COMPANY SNAPSHOT (2022) 437
TABLE 589 SARTORIUS AG: PRODUCTS OFFERED 437
TABLE 590 SARTORIUS AG: PRODUCT LAUNCHES 438
TABLE 591 SARTORIUS AG: DEALS 439
TABLE 592 SARTORIUS AG: EXPANSIONS 439
13.1.4 THERMO FISHER SCIENTIFIC INC. 441
TABLE 593 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 441
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 442
TABLE 594 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 442
TABLE 595 THERMO FISHER SCIENTIFIC INC.: DEALS 443
TABLE 596 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS 444
13.1.5 3M COMPANY 445
TABLE 597 3M COMPANY: BUSINESS OVERVIEW 445
FIGURE 45 3M COMPANY: COMPANY SNAPSHOT (2022) 446
TABLE 598 3M COMPANY: PRODUCTS OFFERED 446
TABLE 599 3M COMPANY: EXPANSIONS 447
13.1.6 PARKER HANNIFIN CORPORATION 448
TABLE 600 PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW 448
FIGURE 46 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2023) 449
TABLE 601 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED 449
TABLE 602 PARKER HANNIFIN CORPORATION: PRODUCT LAUNCHES 450
TABLE 603 PARKER HANNIFIN CORPORATION: DEALS 450
TABLE 604 PARKER HANNIFIN CORPORATION: EXPANSIONS 450
13.1.7 REPLIGEN CORPORATION 451
TABLE 605 REPLIGEN CORPORATION: BUSINESS OVERVIEW 451
FIGURE 47 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2022) 452
TABLE 606 REPLIGEN CORPORATION: PRODUCTS OFFERED 452
TABLE 607 REPLIGEN CORPORATION: PRODUCT LAUNCHES 453
TABLE 608 REPLIGEN CORPORATION: DEALS 454
TABLE 609 REPLIGEN CORPORATION: EXPANSIONS 454
13.1.8 ASAHI KASEI CORPORATION 455
TABLE 610 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 455
FIGURE 48 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022) 456
TABLE 611 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 456
TABLE 612 ASAHI KASEI CORPORATION: EXPANSIONS 457
13.1.9 EATON CORPORATION PLC 458
TABLE 613 EATON CORPORATION PLC: BUSINESS OVERVIEW 458
FIGURE 49 EATON CORPORATION PLC: COMPANY SNAPSHOT (2022) 459
TABLE 614 EATON CORPORATION PLC: PRODUCTS OFFERED 459
TABLE 615 EATON CORPORATION PLC: PRODUCT LAUNCHES 460
13.1.10 GEA GROUP 461
TABLE 616 GEA GROUP: BUSINESS OVERVIEW 461
FIGURE 50 GEA GROUP: COMPANY SNAPSHOT (2022) 462
TABLE 617 GEA GROUP: PRODUCTS OFFERED 463
TABLE 618 GEA GROUP: PRODUCT LAUNCHES 463
13.1.11 CORNING INCORPORATED 464
TABLE 619 CORNING INCORPORATED: BUSINESS OVERVIEW 464
FIGURE 51 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 465
TABLE 620 CORNING INCORPORATED: PRODUCTS OFFERED 465
13.1.12 ALFA LAVAL CORPORATE AB 467
TABLE 621 ALFA LAVAL CORPORATE AB: BUSINESS OVERVIEW 467
FIGURE 52 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2022) 468
TABLE 622 ALFA LAVAL CORPORATE AB: PRODUCTS OFFERED 468
13.1.13 DONALDSON COMPANY, INC. 470
TABLE 623 DONALDSON COMPANY, INC.: BUSINESS OVERVIEW 470
FIGURE 53 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2023) 471
TABLE 624 DONALDSON COMPANY, INC.: PRODUCTS OFFERED 471
TABLE 625 DONALDSON COMPANY, INC.: PRODUCT LAUNCHES 472
TABLE 626 DONALDSON COMPANY, INC.: DEALS 472
TABLE 627 DONALDSON COMPANY, INC.: EXPANSIONS 473
13.1.14 SAINT-GOBAIN 474
TABLE 628 SAINT-GOBAIN: BUSINESS OVERVIEW 474
FIGURE 54 SAINT-GOBAIN: COMPANY SNAPSHOT (2022) 474
TABLE 629 SAINT-GOBAIN: PRODUCTS OFFERED 475
13.1.15 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG 476
TABLE 630 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: BUSINESS OVERVIEW 476
FIGURE 55 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: COMPANY SNAPSHOT (2022) 477
TABLE 631 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: PRODUCTS OFFERED 477
13.1.16 MEISSNER FILTRATION PRODUCTS, INC. 478
TABLE 632 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW 478
TABLE 633 MEISSNER FILTRATION PRODUCTS, INC.: PRODUCTS OFFERED 478
TABLE 634 MEISSNER FILTRATION PRODUCTS, INC.: EXPANSIONS 479
13.1.17 COLE-PARMER INSTRUMENT COMPANY, LLC 480
TABLE 635 COLE-PARMER INSTRUMENT COMPANY, LLC.: BUSINESS OVERVIEW 480
TABLE 636 COLE-PARMER INSTRUMENT COMPANY, LLC.: PRODUCTS OFFERED 480
13.1.18 APPLEXION 481
TABLE 637 APPLEXION: BUSINESS OVERVIEW 481
TABLE 638 APPLEXION: PRODUCTS OFFERED 481
13.1.19 CANTEL MEDICAL CORP. 482
TABLE 639 CANTEL MEDICAL CORP.: BUSINESS OVERVIEW 482
TABLE 640 CANTEL MEDICAL CORP.: PRODUCTS OFFERED 482
13.1.20 W. L. GORE & ASSOCIATES, INC. 483
TABLE 641 W. L. GORE & ASSOCIATES, INC.: BUSINESS OVERVIEW 483
TABLE 642 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED 483
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS 484
13.2.1 MEMBRANE SOLUTIONS 484
TABLE 643 MEMBRANE SOLUTIONS: BUSINESS OVERVIEW 484
13.2.2 AMAZON FILTERS LTD. 485
TABLE 644 AMAZON FILTERS LTD.: BUSINESS OVERVIEW 485
13.2.3 TOYO ROSHI KAISHA, LTD. 486
TABLE 645 TOYO ROSHI KAISHA, LTD.: BUSINESS OVERVIEW 486
13.2.4 PORVAIR PLC 487
TABLE 646 PORVAIR PLC: BUSINESS OVERVIEW 487
13.2.5 STERLITECH CORPORATION 488
TABLE 647 STERLITECH CORPORATION: BUSINESS OVERVIEW 488
13.2.6 SYNDER FILTRATION, INC. 489
TABLE 648 SYNDER FILTRATION, INC.: BUSINESS OVERVIEW 489
13.2.7 GRAVER TECHNOLOGIES, LLC 490
TABLE 649 GRAVER TECHNOLOGIES, LLC: BUSINESS OVERVIEW 490
13.2.8 KOCH MEMBRANE SYSTEMS, INC. 491
TABLE 650 KOCH MEMBRANE SYSTEMS, INC.: BUSINESS OVERVIEW 491
13.2.9 NUPORE FILTRATION SYSTEMS 492
TABLE 651 NUPORE FILTRATION SYSTEMS: BUSINESS OVERVIEW 492
13.2.10 COBETTER FILTRATION EQUIPMENT CO., LTD. 492
TABLE 652 COBETTER FILTRATION EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 492
14 APPENDIX 493
14.1 DISCUSSION GUIDE 493
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 498
14.3 CUSTOMIZATION OPTIONS 500
14.4 RELATED REPORTS 501
14.5 AUTHOR DETAILS 502

*** 医薬品用膜ろ過の世界市場に関するよくある質問(FAQ) ***

・医薬品用膜ろ過の世界市場規模は?
→MarketsandMarkets社は2024年の医薬品用膜ろ過の世界市場規模を106億米ドルと推定しています。

・医薬品用膜ろ過の世界市場予測は?
→MarketsandMarkets社は2029年の医薬品用膜ろ過の世界市場規模を196億米ドルと予測しています。

・医薬品用膜ろ過市場の成長率は?
→MarketsandMarkets社は医薬品用膜ろ過の世界市場が2024年~2029年に年平均13.1%成長すると展望しています。

・世界の医薬品用膜ろ過市場における主要プレイヤーは?
→「Thermo Fisher Scientific Inc.(米国)、Merck KGaA(ドイツ)、Danaher Corporation(米国)、Sartorius AG(ドイツ)、Thermo Fisher Scientific, Inc. (米国)、3M Company(米国)、Parker Hannifin Corporation(米国)、Repligen Corporation(米国)、旭化成株式会社(日本)、Eaton Corporation plc(アイルランド)、GEA Group(ドイツ)など ...」を医薬品用膜ろ過市場のグローバル主要プレイヤーとして判断しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BT2255-24 )"医薬品用膜ろ過の世界市場予測(~2029):製品別、技術別、用途​​別、種類別、運営規模別" (英文:Pharmaceutical Membrane Filtration Market by Product (Filters (PES, PVDF, Nylon), Systems (Single use)), Technique (Microfiltration, Ultrafiltration), Application (API, Vaccines), Type (Sterile, Non Sterile), Scale of Operation - Global Forecast to 2029)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。